CDC reports on AR burden

CDC reports antimicrobial resistance (AR) is still an urgent threat in U.S.

New Data Show Antimicrobial-resistant Pathogens Remain Elevated Post-pandemic

CDC used new data to analyze the U.S. burden of seven antimicrobial-resistant pathogens typically found in healthcare settings from 2021 through 2022. A new fact sheet shows that six bacterial antimicrobial-resistant hospital-onset infections increased by a combined 20% during the COVID-19 pandemic compared to the pre-pandemic period, peaking in 2021, and remaining above pre-pandemic levels in 2022.  In 2022, rates for all but one of these pathogens (methicillin-resistant Staphylococcus aureus or MRSA) remain above pre-pandemic levels. In addition, the number of reported clinical cases of Candida auris (C. auris)—a type of yeast that can spread in healthcare facilities, is often resistant to antifungal medications, and causes severe illness—increased nearly five-fold from 2019 to 2022.

The release of this fact sheet is an opportunity to highlight how data are critical to guide efforts to combat antimicrobial resistance, and CDC is committed to providing the high-quality data required to steer this important work.  Download and share the fact sheet outlining the new data and visit CDC’s website for more information on antimicrobial resistance threats in the U.S.

	NEW CDC report underscores #AntimicrobialResistance remains an urgent #PublicHealth threat. Check out the new data and share with others who are working to continue the fight against AR. bit.ly/ARThreats2022

Don’t forget to follow us on X @CDC_AR. If this email was forwarded to you, join our email list to stay up to date with CDC’s antimicrobial resistance news.

Centers for Disease Control and Prevention 1600 Clifton Rd   Atlanta, GA 30329   1-800-CDC-INFO (800-232-4636)   TTY: 888-232-6348 Questions or Problems  |  Unsubscribe